The clinical evidence for combining keto with GLP-1 therapy Research on this specific combination is still emerging, but the studies that do exist tell a compelling story
GLP-1 receptor agonist medications mimic the action of glucagon-like peptide 1 (GLP-1), a hormone secreted by your intestines when you eat
These small proteins target metabolism, hunger, and fat loss, offering new hope for those who need extra support on their weight loss journey
Similar considerations may limit the utility of the injectable agents, tirzepatide (dual GLP-1 and glucose-dependent insulinotropic polypeptide [GIP] agonist), and retatrutide (triple glucagon, GIP, and GLP-1 receptor agonist)
What is compounded tirzepatide, and why does it matter
We sought to assess how such discontinuation affects weight gain and outcomes during pregnancy. For the study, the team analyzed electronic health records for 1,792 pregnancies delivered within the Mass General Brigham healthcare system between 20162025, primarily among women with obesity